icon-folder.gif   Conference Reports for NATAP  
 
  IDSA
ID Week 2026
October 21-24
Washington, DC

Back grey_arrow_rt.gif
 
 
 
Virologic Outcomes Following Transition to Long-Acting Injectable
Cabotegravir/Rilpivirine: Comparison of Prior Two-Drug vs Three-Drug Oral Regimens
 

 
 
  IDSA 2026 October 21-24 Wash DC
 

1022261opy

1022262copy

1022263opy

1022264copy

1022265copy